Mohammad Ahmadi

Dr. Mohammad Ahmadi


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2023 in IJC Heart & Vasculature
Verified
Journal Article
Open access
MAMohammad Ahmadi
Mohammad Ahmadi
SAShana Ahadi
Shana Ahadi
MKMohammad Amin Khadembashiri
Mohammad Amin Khadembashiri
MKmohmad mehdi khadembashiri
mohmad mehdi khadembashiri
MMMehrdad Mahalleh
Mehrdad Mahalleh
ASAli Akbari Sari
Ali Akbari Sari
Despite the burden of ischemic heart disease (IHD), there remains a paucity of research on the incidence, mortality, and burden of this condition in the Middle East and North Africa (MENA) regions. This study aimed to evaluate the epidemiology and the risk factors associated with IHD in the MENA region. This study was performed based on the GBD study 2019 data. We retrieved the data related to the epidemiology and burden of IHD, including prevalence, incidence, years of life lost due to premature death (YLLs), years lived with disability (YLDs), and mortality at the global level and in MENA countries across years and sexes. IHD accounted for approximately 2.55 million (95 % UI 2.29–2.83) incident cases in MENA in 2019, with an age-standardized incidence rate of 613.87 (95 % UI 555.84–675.16) per 100 000 people, which has decreased by 9 % between 1990 and 2019. IHD accounted for 11.01 % of DALYs causes in MENA in 2019, an increase of 68 % compared to 1990. The DALYs rate from IHD increased with age in both men and women and was higher in men than in women in all age groups, except 85–89 years age-group, in 2019. The age-standardized prevalence and incidence of IHD are decreasing in MENA. However, this reduction is lower than the global level, which can be due to a weaker performance of the countries in the region in reducing the prevalence and incidence of the disease compared to the global average.

16 January 2024 in Clinical Cardiology
Verified
Journal Article
Open access
HSHamid Reza Sabet
Hamid Reza Sabet
MAMohammad Ahmadi
Mohammad Ahmadi
MAMehdi Akrami
Mehdi Akrami
MMMahsa Motamed
Mahsa Motamed
OKOmid Keshavarzian
Omid Keshavarzian
HAHamed Akbari
Hamed Akbari
This meta‐analysis aimed to evaluate the effects of flaxseed supplementation on weight loss, lipid profiles, high‐sensitivity C‐reactive protein (hs‐CRP), and glucose levels in patients with coronary artery disease (CAD). A systematic search was performed using various online databases, including Scopus, PubMed, Web of Science, EMBASE, and Cochrane Library, to identify relevant randomized controlled trials (RCTs) until June 2023. To evaluate heterogeneity among the selected studies, the Q‐test and I2 statistics were employed. Data were combined using either a fixed‐ or random‐effects model and presented as a weighted mean difference (WMD) with a 95% confidence interval (CI). Of the 428 citations, six RCTs were included. The pooled results did not show significant changes in the WMD of lipid factors (high‐density lipoprotein cholesterol, triglycerides (TG), low‐density lipoprotein cholesterol, and total cholesterol) following flaxseed intake. However, after performing a sensitivity analysis to determine the source of heterogeneity, flaxseed supplementation resulted in a significant decrease in TG levels (WMD = −18.39 mg/dL; 95% CI: −35.02, −1.75). Moreover, no significant differences were observed in either weight or BMI following flaxseed intake. However, the circulating levels of fasting blood glucose (WMD = −8.35 mg/dL; 95% CI: −15.01, −1.69, p = .01) and hs‐CRP (WMD = −1.35 mg/L; 95% CI: −1.93, −0.77, p < .01) significantly decreased after the intervention. Flaxseed supplementation was associated with lowering FBS, hs‐CRP, and TG levels but did not affect weight loss parameters and other lipid markers in CAD.

21 May 2024 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
NENiloofarsadaat Eshaghhosseiny
Niloofarsadaat Eshaghhosseiny
MAMohammad Ahmadi
Mohammad Ahmadi
BIBahareh Izadi
Bahareh Izadi
MVMohebat Vali
Mohebat Vali
MAMaryam Akbari
Maryam Akbari
HAHamed Akbari
Hamed Akbari

13 February 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MKMohamad A. Khadembashiri
Mohamad A. Khadembashiri
MKMohammad Saeid Khonji
Mohammad Saeid Khonji
TATannaz Ahadi
Tannaz Ahadi
BFBijan Forogh
Bijan Forogh
NMNiloofar Mirdamadi
Niloofar Mirdamadi
GRGholamreza Raissi
Gholamreza Raissi
Background: Neck pain (NP) is a condition influenced by multiple factors. It places a significant burden on individuals suffering from NP and on social and economic systems. On a global scale, low back pain (LBP) stands out as a significant contributor to years lost to disability, and this burden is on the rise due to population growth and aging. Methods: The Global Burden of Disease database was used to collect data on the prevalence, incidence, and years lived with disability (YLD) of NP and LBP between 1990 and 2019. Various factors, including age group, gender, Iran, and its 31 provinces, were used to classify the data. Results: Iran accounted for 0.86 million incident cases of NP in 2019, with age-standardized incident rate per 100 000 population of 934.1. Tehran has the maximum age-standardized prevalence, incidence, and YLD. Iran accounted for the age-standardized incidence rate for LBP per 100 000 population of 3492.9, and it reduced to −8.35% from 1990. Mazandaran exhibits the highest levels of prevalence, incidence, and YLD for LBP in 2019. In Iran, the point prevalence of NP in 2019 was higher in females and increased with age up to 50–54 years for females and 70–74 years for males. However, there is only a slight difference between females and males in Iran regarding LBP prevalence. Conclusions: In this study, the authors report the prevalence, incidence, YLD, and age-standardized rates for NP and LBP in the world’s general population and Iran’s population based on its sub-nations in 1990 and 2019.


4 March 2026 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
ZMZahra Mohammadi
Zahra Mohammadi
SBSina Bazmi
Sina Bazmi
MAMohammad Ahmadi
Mohammad Ahmadi
SKSina Kardeh
Sina Kardeh
RTReza Tabrizi
Reza Tabrizi
Prolongation of the corrected QT interval (QTc) reflects delayed ventricular repolarization and predisposes patients to malignant arrhythmias and sudden ca